Qu Biologics' poster " Site Specific Immunomodulation - A Novel Therapeutic Approach for the Management of Moderate-to-Severe Crohn's Disease " will present results from a Crohn's disease compassionate use program of patients treated with the company's Site Specific Immunomodulators investigational treatment.
More...
More...